Simona John von Freyend

Dr. Simona John von Freyend

orcid

Research Focus & Metrics

Academic Career Length

17Years (2010-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
16 June 2010 in Rapid Communications in Mass Spectrometry
Verified
Journal Article
Closed access
PDF file
LZLiang Zheng
Liang Zheng
RTRuben T'KInd
Ruben T'KInd
SDSaskia Decuypere
Saskia Decuypere
SFSimona John von Freyend
Simona John von Freyend
GCGraham H. Coombs
Graham H. Coombs
David WatsonDavid Watson
David Watson

11 August 2020 in Nature Communications
Verified
Journal Article
Open access
PDF file
JAJack D. Adderley
Jack D. Adderley
SFSimona John von Freyend
Simona John von Freyend
SJSarah A. Jackson
Sarah A. Jackson
MBMegan J. Bird
Megan J. Bird
ABAmy L. Burns
Amy L. Burns
CDChristian Doerig
Christian Doerig
Intracellular pathogens mobilize host signaling pathways of their host cell to promote their own survival. Evidence is emerging that signal transduction elements are activated in a-nucleated erythrocytes in response to infection with malaria parasites, but the extent of this phenomenon remains unknown. Here, we fill this knowledge gap through a comprehensive and dynamic assessment of host erythrocyte signaling during infection with Plasmodium falciparum. We used arrays of 878 antibodies directed against human signaling proteins to interrogate the activation status of host erythrocyte phospho-signaling pathways at three blood stages of parasite asexual development. This analysis reveals a dynamic modulation of many host signalling proteins across parasite development. Here we focus on the hepatocyte growth factor receptor (c-MET) and the MAP kinase pathway component B-Raf, providing a proof of concept that human signaling kinases identified as activated by malaria infection represent attractive targets for antimalarial intervention.

1 July 2010 in International Journal for Parasitology
Verified
Journal Article
Closed access
SFSimona John von Freyend
Simona John von Freyend
HRHeidi Rosenqvist
Heidi Rosenqvist
AFAnnette Fink
Annette Fink
IMInga Maria Melzer
Inga Maria Melzer
JCJoachim Clos
Joachim Clos
MWMartin Wiese
Martin Wiese

1 July 2016 in Molecular and Biochemical Parasitology
Verified
Journal Article
Closed access
TCTeresa Gil Carvalho
Teresa Gil Carvalho
BMBelinda Morahan
Belinda Morahan
SFSimona John von Freyend
Simona John von Freyend
PBPhilippe Boeuf
Philippe Boeuf
Georges Emile GrauGeorges Emile Grau
Georges Emile Grau
CDChristian Doerig
Christian Doerig

21 April 2017 in Pathogens
Verified
Journal Article
Open access
PDF file
SFSimona John von Freyend
Simona John von Freyend
TKTerry Kwok
Terry Kwok
HNHans Netter
Hans Netter
GHGholamreza Haqshenas
Gholamreza Haqshenas
JSJean-Philippe Semblat
Jean-Philippe Semblat
CDChristian Doerig
Christian Doerig
Intracellular pathogens have evolved a wide range of strategies to not only escape from the immune systems of their hosts, but also to directly exploit a variety of host factors to facilitate the infection process. One such strategy is to subvert host cell signalling pathways to the advantage of the pathogen. Recent research has highlighted that the human serine/threonine kinase PAK, or p21-activated kinase, is a central component of host-pathogen interactions in many infection systems involving viruses, bacteria, and eukaryotic pathogens. PAK paralogues are found in most mammalian tissues, where they play vital roles in a wide range of functions. The role of PAKs in cell proliferation and survival, and their involvement in a number of cancers, is of great interest in the context of drug discovery. In this review we discuss the latest insights into the surprisingly central role human PAK1 plays for the infection by such different infectious disease agents as viruses, bacteria, and parasitic protists. It is our intention to open serious discussion on the applicability of PAK inhibitors for the treatment, not only of neoplastic diseases, which is currently the primary objective of drug discovery research targeting these enzymes, but also of a wide range of infectious diseases.

18 February 2012 in Extremophiles
Verified
Journal Article
Open access
PDF file
SFSusan Fischer
Susan Fischer
SFSimona John von Freyend
Simona John von Freyend
ASAnice Sabag-Daigle
Anice Sabag-Daigle
CDCharles J. Daniels
Charles J. Daniels
Thorsten AllersThorsten Allers
Thorsten Allers
Anita MarchfelderAnita Marchfelder
Anita Marchfelder
The metallo-β-lactamase family of enzymes comprises a large group of proteins with diverse functions in the metabolism of the cell. Among others, this superfamily contains proteins which are involved in DNA and RNA metabolism, acting as nucleases in e.g. repair and maturation. Many proteins have been annotated in prokaryotic genomes as being potential metallo-β-lactamases, but very often the function has not been proven. The protein HVO_2763 from Haloferax volcanii is such a potential metallo-β-lactamase. HVO_2763 has sequence similarity to the metallo-β-lactamase tRNase Z, a tRNA 3′ processing endonuclease. Here, we report the characterisation of this metallo-β-lactamase HVO_2763 in the halophilic archaeon Haloferax volcanii. Using different in vitro assays with the recombinant HVO_2763, we could show that the protein does not have tRNA 3′ processing or exonuclease activity. According to transcriptome analyses of the HVO_2763 deletion strain, expression of proteins involved in membrane transport is downregulated in the mutant. Therefore, HVO_2763 might be involved directly or indirectly in membrane transport.